Replies to post #267379 on Avid Bioservices Inc (CDMO)

[vinmantoo]

vimantoo, you are missing your own point here. We were not talking about the PD-1/PD-L1. We were talking about 10+ PS receptor drugs to COMBINE with PD-1/PD-L1 vesus PS target (Bavituximab) one drug to combine with PD-1/PD-L1.

So your reply is besides the point because I never said the PD-1/PD-L1 doesn't work. BMY/Merck and others proved otherwise.

You kept claiming that the anti+PS antibody approach, specifically Bavi, is equivalent to using a combination of 10-12 anti-receptor/ligand antibodies. There is nothing to support that view as Bavi has failed repeatedly as a single agent or with chemo whereas single agent anti-receptors or anti-ligand approaches have worked well enough to merit FDA approval. The limited clinical trial data using combinations of two of such anti-receptor or anti-ligand approaches have showed synergistic improvements.